Biocross

Degenerative Dementia test

Biomarkers / Diagnostic
Central Nervous System
The Degenerative Dementia test is based on the detection and quantification of up to 7 blood biomarkers that are specifically altered in patients affected by neurodegeneration due to FTD or AD. The DD test is conceived as a “screening” tool for use in cl
2Preclinical Validation, 1R+D
Europe